4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001308
General Counsel acquired 28,000 shares (option exercise)
- General Counsel acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
O'Brien Patrick · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-31 | Exercise or conversion : show line 1 in the form | +28,000 | $6.15 | $172,200 | 321,375 | D |
| 2022-01-01 | Grant or award : show line 2 in the form | +60,000 | 381,375 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-31 | Exercise or conversion : show line 3 in the form Stock Option (right to buy Common Stock) | −28,000 | 32,000 | D |
Loading xslF345X03/doc4.xml…